Cargando…
SELDI-TOF mass spectrometry of High-Density Lipoprotein
BACKGROUND: High-Density Lipoprotein (HDL), one of the main plasma lipoproteins, serves as a docking station for proteins involved in inflammation, coagulation, and lipid metabolism. METHODS: To elucidate the protein composition of HDL, we employed SELDI-TOF mass spectrometry as a potential high-thr...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020459/ https://www.ncbi.nlm.nih.gov/pubmed/17822561 http://dx.doi.org/10.1186/1477-5956-5-15 |
_version_ | 1782136599173136384 |
---|---|
author | Levels, Johannes HM Bleijlevens, Boris Rezaee, Farhad Aerts, Johannes MFG Meijers, Joost CM |
author_facet | Levels, Johannes HM Bleijlevens, Boris Rezaee, Farhad Aerts, Johannes MFG Meijers, Joost CM |
author_sort | Levels, Johannes HM |
collection | PubMed |
description | BACKGROUND: High-Density Lipoprotein (HDL), one of the main plasma lipoproteins, serves as a docking station for proteins involved in inflammation, coagulation, and lipid metabolism. METHODS: To elucidate the protein composition of HDL, we employed SELDI-TOF mass spectrometry as a potential high-throughput proteomic candidate for protein profiling of HDL. HDL derived from normolipemic individuals was captured on PS20 protein-chips using covalently bound antibodies against apo A-I or A-II. RESULTS: After optimisation, on-chip capture of HDL particles directly from plasma or from pre-purified HDL resulted in comparable fingerprints confirming specific capture of HDL. Depending on the capture antibody some differences in the fingerprint were observed. The most detailed fingerprint was observed up to 50 kDa; approximately 95 peaks were detected in the 3–50 kDa molecular mass range. Between 50 and 160 kDa, 27 more peaks were detected. CONCLUSION: Based on these results, SELDI-TOF MS may be a suitable high-throughput candidate for HDL protein profiling and marker search. This approach may be used to i) investigate the underlying mechanisms that lead to increased atherothrombotic risk and ii) to investigate the atherothrombotic state of an individual. |
format | Text |
id | pubmed-2020459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-20204592007-10-13 SELDI-TOF mass spectrometry of High-Density Lipoprotein Levels, Johannes HM Bleijlevens, Boris Rezaee, Farhad Aerts, Johannes MFG Meijers, Joost CM Proteome Sci Methodology BACKGROUND: High-Density Lipoprotein (HDL), one of the main plasma lipoproteins, serves as a docking station for proteins involved in inflammation, coagulation, and lipid metabolism. METHODS: To elucidate the protein composition of HDL, we employed SELDI-TOF mass spectrometry as a potential high-throughput proteomic candidate for protein profiling of HDL. HDL derived from normolipemic individuals was captured on PS20 protein-chips using covalently bound antibodies against apo A-I or A-II. RESULTS: After optimisation, on-chip capture of HDL particles directly from plasma or from pre-purified HDL resulted in comparable fingerprints confirming specific capture of HDL. Depending on the capture antibody some differences in the fingerprint were observed. The most detailed fingerprint was observed up to 50 kDa; approximately 95 peaks were detected in the 3–50 kDa molecular mass range. Between 50 and 160 kDa, 27 more peaks were detected. CONCLUSION: Based on these results, SELDI-TOF MS may be a suitable high-throughput candidate for HDL protein profiling and marker search. This approach may be used to i) investigate the underlying mechanisms that lead to increased atherothrombotic risk and ii) to investigate the atherothrombotic state of an individual. BioMed Central 2007-09-06 /pmc/articles/PMC2020459/ /pubmed/17822561 http://dx.doi.org/10.1186/1477-5956-5-15 Text en Copyright © 2007 Levels et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Levels, Johannes HM Bleijlevens, Boris Rezaee, Farhad Aerts, Johannes MFG Meijers, Joost CM SELDI-TOF mass spectrometry of High-Density Lipoprotein |
title | SELDI-TOF mass spectrometry of High-Density Lipoprotein |
title_full | SELDI-TOF mass spectrometry of High-Density Lipoprotein |
title_fullStr | SELDI-TOF mass spectrometry of High-Density Lipoprotein |
title_full_unstemmed | SELDI-TOF mass spectrometry of High-Density Lipoprotein |
title_short | SELDI-TOF mass spectrometry of High-Density Lipoprotein |
title_sort | seldi-tof mass spectrometry of high-density lipoprotein |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020459/ https://www.ncbi.nlm.nih.gov/pubmed/17822561 http://dx.doi.org/10.1186/1477-5956-5-15 |
work_keys_str_mv | AT levelsjohanneshm selditofmassspectrometryofhighdensitylipoprotein AT bleijlevensboris selditofmassspectrometryofhighdensitylipoprotein AT rezaeefarhad selditofmassspectrometryofhighdensitylipoprotein AT aertsjohannesmfg selditofmassspectrometryofhighdensitylipoprotein AT meijersjoostcm selditofmassspectrometryofhighdensitylipoprotein |